“313” Mineral Wool Insulation Cement
Manufacturer: G-I Holdings (GAF Corporation predecessor/successor entity) Product Category: Pipe Insulation Years Produced: 1960–1971 Asbestos Type: Chrysotile
Product Description
The “313” Mineral Wool Insulation Cement was a finishing and pipe insulation cement manufactured by G-I Holdings, the corporate entity associated with GAF Corporation, during the period spanning 1960 through 1971. Products of this type were designed primarily for industrial pipe insulation applications, where they served as finishing cements applied over pre-formed pipe insulation or as a standalone insulating layer on pipes, fittings, and irregular surfaces in industrial facilities.
Mineral wool insulation cements of this era were workhouse materials in heavy industrial construction and maintenance. The “313” formulation was intended for use in environments requiring thermal insulation on piping systems, including those found in manufacturing plants, refineries, chemical processing facilities, and power generation installations. The cement form factor allowed workers to trowel or hand-apply the material directly onto pipe surfaces, pack it into irregular fittings, and build up insulation thickness where pre-formed sectional insulation could not be used alone.
As with many industrial insulation products manufactured during the mid-twentieth century, the “313” Mineral Wool Insulation Cement incorporated asbestos fiber as a functional additive — a practice that was widespread across the insulation manufacturing industry during the decades of its production.
Asbestos Content
The “313” Mineral Wool Insulation Cement contained chrysotile asbestos as a component of its formulation. Chrysotile, also known as white asbestos, is a serpentine-form asbestos mineral that was the most commercially prevalent asbestos variety used in manufactured construction and insulation products throughout the twentieth century.
In cement-type insulation products, chrysotile served several functional roles. The fibrous structure of chrysotile reinforced the cementitious matrix, improving tensile strength and resistance to cracking after application and drying. The mineral also contributed to the product’s thermal resistance properties and helped bind the mineral wool aggregate within the cement mixture, preventing the finished application from becoming brittle or friable under thermal cycling conditions.
Chrysotile asbestos has been classified as a known human carcinogen by the International Agency for Research on Cancer (IARC) and is regulated as a hazardous material under the Occupational Safety and Health Administration (OSHA) standards and the Asbestos Hazard Emergency Response Act (AHERA). All commercially used forms of asbestos, including chrysotile, are associated with the development of mesothelioma, asbestosis, and lung cancer following occupational inhalation exposure. No safe threshold of exposure to chrysotile asbestos has been established by occupational health regulatory authorities.
How Workers Were Exposed
Industrial workers who handled, mixed, applied, or worked in proximity to the “313” Mineral Wool Insulation Cement during its years of production represent the primary population with documented exposure potential.
Mixing and Preparation: Insulation cements of this type were typically supplied as a dry or semi-dry powder that required workers to mix the material with water before application. The mixing process generated significant airborne dust, which would have contained chrysotile fibers in concentrations well above background levels. Workers performing this task in enclosed or poorly ventilated industrial settings faced repeated and potentially heavy fiber inhalation during each mix cycle.
Application: Workers applying the cement by trowel, brush, or hand to pipe surfaces disturbed the mixed material in ways that could release additional fiber into the breathing zone. Pipe fitters, insulators, and general industrial maintenance personnel who physically worked the material onto surfaces and shaped it around fittings and valves were in close and prolonged contact with the product during each application task.
Cutting and Finishing: After the applied cement dried, workers often needed to trim excess material, smooth edges, or cut through existing applications during maintenance or repair operations. Dry cutting, grinding, or abrasive removal of hardened asbestos-containing insulation cement is known to release concentrated fiber bursts into the immediate work environment.
Bystander Exposure: Workers in industrial facilities who were not directly handling the “313” product but who were present in the same work areas during its application or disturbance were also subject to secondhand fiber exposure. In industrial settings with shared workspaces, inadequate ventilation, or simultaneous trades working in close quarters, bystander exposure to airborne chrysotile fibers was common during the era when personal protective equipment standards and exposure monitoring requirements were far less stringent than those established by later OSHA regulation.
The latency period between asbestos fiber inhalation and the development of related disease — including mesothelioma — typically ranges from 20 to 50 years, meaning workers exposed to the “313” product during its production years of 1960 through 1971 may only have received confirmed diagnoses in more recent decades.
Documented Trust Fund / Legal Options
Trust Fund Status: No dedicated asbestos bankruptcy trust has been identified for claims specifically arising from the “313” Mineral Wool Insulation Cement manufactured by G-I Holdings.
Litigation History: Litigation records document that G-I Holdings has been named as a defendant in asbestos personal injury litigation in connection with asbestos-containing products associated with the GAF corporate lineage. Plaintiffs alleged exposure to asbestos-containing products manufactured or distributed under the G-I Holdings and GAF corporate entities and further alleged that the manufacturers knew or should have known of the hazards associated with asbestos inhalation during the period of the product’s manufacture and sale.
Plaintiffs alleged that adequate warnings were not provided to end users, contractors, or industrial workers who routinely handled these products, and that this failure to warn contributed directly to occupational asbestos exposure and resulting disease.
Legal Pathways for Affected Workers:
Individuals diagnosed with mesothelioma, asbestosis, lung cancer, or other asbestos-related diseases who have a documented or credible history of exposure to the “313” Mineral Wool Insulation Cement may have viable legal claims. Available pathways include:
- Direct civil litigation against G-I Holdings or successor corporate entities in state or federal court
- Multi-defendant litigation consolidating claims against multiple manufacturers whose asbestos-containing products were used at the same job sites
- Claims against other applicable asbestos bankruptcy trusts if co-exposure to products from bankrupt manufacturers can be established through work history documentation
Workers, former employees, or their surviving family members seeking to evaluate potential claims should consult with an attorney experienced in asbestos personal injury litigation. Statutes of limitations for asbestos claims vary by state and typically run from the date of diagnosis or the date a claimant knew or reasonably should have known of the connection between their illness and asbestos exposure.
This article documents publicly available information derived from product records, litigation history, and regulatory filings. It is intended as factual reference material and does not constitute legal advice.